Regeneron Pharmaceuticals P/CF Ratio 2011-2026 | REGN

Annual P/CF Ratio Regeneron Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.3	17.6	21.8	16.7	9.43	19.9	18.4	25	39	37.5	66.3	102	67.1	-133	-40.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
102	-133	18.9

P/CF Ratio of other stocks in the Biotechnology industry

Issuer	P/CF Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.654	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	-0.266	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	11.6	-	-	$ 40.3 B	USA
Genfit SA GNFT	1.68 K	-	2.54 %	$ 160 B	France
Autolus Therapeutics plc AUTL	-1.14	$ 1.34	-3.6 %	$ 357 M	Britain
Biophytis SA BPTS	-23.1	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	-13.2	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.88	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	-1.2	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	-23.3	$ 20.13	-1.13 %	$ 2.81 B	France
Alterity Therapeutics Limited ATHE	-94.9	$ 3.65	1.3 %	$ 8.78 B	Australia
Advaxis ADXS	-0.0633	-	-9.65 %	$ 45.9 M	USA
Dyadic International DYAI	-5.52	$ 0.87	-	$ 31.5 M	USA
Adverum Biotechnologies ADVM	-0.826	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	-8.14	$ 2.57	-3.57 %	$ 16.1 M	USA
Институт стволовых клеток человека ISKJ	-89	-	-	-	Russia
Equillium EQ	-5.19	$ 2.04	1.24 %	$ 117 M	USA
Aeterna Zentaris AEZS	-4.82	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.0018	-	-10.17 %	$ 12.2 K	USA
Fate Therapeutics FATE	-1.76	$ 1.13	-5.04 %	$ 134 M	USA
Aeglea BioTherapeutics AGLE	-4.6	-	-	$ 1.01 B	USA
Forte Biosciences FBRX	-6.59	$ 26.57	0.49 %	$ 344 M	USA
Applied Genetic Technologies Corporation AGTC	-0.64	-	-	$ 26.5 M	USA
Fennec Pharmaceuticals FENC	-13.5	$ 6.14	-4.36 %	$ 175 M	USA
Foghorn Therapeutics FHTX	-4.13	$ 4.74	-2.87 %	$ 299 M	USA
AIkido Pharma AIKI	-1.17	-	1.93 %	$ 17.4 M	USA
Amicus Therapeutics FOLD	134	$ 14.46	0.03 %	$ 4.46 B	USA
Aptose Biosciences APTO	-0.0645	-	-45.71 %	$ 1.2 M	Canada
Fulcrum Therapeutics FULC	-0.00898	$ 7.55	-3.58 %	$ 478 K	USA
Galectin Therapeutics GALT	-7.47	$ 2.25	-12.3 %	$ 144 M	USA
Akero Therapeutics AKRO	-14.1	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-4.82	-	-	$ 867 M	Germany
BioNTech SE BNTX	70.7	$ 87.65	-3.98 %	$ 27.2 B	Germany
Gilead Sciences GILD	18.3	$ 138.19	-1.38 %	$ 172 B	USA
Coherus BioSciences CHRS	-1.63	$ 1.61	-3.59 %	$ 189 M	USA
Akari Therapeutics, Plc AKTX	-765	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	-2.7	-	0.23 %	$ 488 M	USA
Galmed Pharmaceuticals Ltd. GLMD	-0.212	$ 0.54	4.26 %	$ 503 K	Israel
Genmab A/S GMAB	4.08	$ 27.01	-2.67 %	$ 17.2 B	Danmark
Allakos ALLK	-0.976	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	-2.48	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	77.9	$ 314.44	-4.81 %	$ 41.2 B	USA
Gossamer Bio GOSS	-0.627	$ 0.32	-7.11 %	$ 73.1 M	USA
Grifols, S.A. GRFS	14.1	$ 7.91	-3.95 %	$ 6.83 B	Spain
Alpine Immune Sciences ALPN	-6.14	-	-	$ 2.17 B	USA
GT Biopharma GTBP	-0.201	$ 0.42	-6.49 %	$ 2.32 M	USA
Aileron Therapeutics ALRN	-1.71	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	-0.632	-	4.14 %	$ 49.1 M	USA
Halozyme Therapeutics HALO	14.8	$ 63.51	0.68 %	$ 7.61 B	USA
Burford Capital Limited BUR	11.6	$ 4.42	-1.34 %	$ 727 M	Britain